Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -41.45%11.12M | 193.54%41.31M | 111.88%9.17M | -69.59%2.51M | 206.83%10.64M | 1,054.98%18.99M | 417.51%14.07M | -79.34%4.33M | 141.94%8.27M | 919.86%3.47M |
| Net profit before non-cash adjustment | 213.12%7.04M | 134.42%5.92M | 107.90%877K | 62.86%-2.92M | 4,777.05%5.71M | 18.57%2.25M | 54.26%-17.19M | 71.68%-11.11M | -7.30%-7.85M | -103.28%-122K |
| Total adjustment of non-cash items | -60.93%2.3M | -30.70%18.01M | -49.68%5.07M | -48.11%3.1M | -47.19%3.96M | 140.57%5.88M | -46.82%25.99M | -68.31%10.07M | 7.86%5.97M | 27.33%7.5M |
| -Depreciation and amortization | ---- | -0.31%14.8M | ---- | ---- | ---- | ---- | -6.19%14.85M | ---- | ---- | ---- |
| -Reversal of impairment losses recognized in profit and loss | ---- | -125.23%-1.66M | ---- | ---- | ---- | ---- | -71.93%6.58M | ---- | ---- | ---- |
| -Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Share of associates | -5.66%100K | 22.74%610K | -76.26%118K | --93K | --293K | --106K | 324.79%497K | --497K | --0 | --0 |
| -Disposal profit | --0 | 28.33%-296K | 28.33%-296K | --0 | --0 | --0 | -35.86%-413K | ---413K | --0 | --0 |
| -Net exchange gains and losses | ---- | 1,371.43%721K | ---- | ---- | ---- | ---- | -79.75%49K | ---- | ---- | ---- |
| -Other non-cash items | -61.95%2.2M | -13.42%3.83M | 25.00%-8.62M | -49.66%3.01M | -51.09%3.67M | 136.24%5.78M | -29.13%4.43M | -5.95%-11.49M | 7.86%5.97M | 27.33%7.5M |
| Changes in working capital | -83.61%1.78M | 229.68%17.38M | -39.91%3.23M | -77.03%2.33M | 124.87%973K | 271.51%10.86M | 133.54%5.27M | -81.09%5.37M | 156.61%10.15M | 61.00%-3.91M |
| -Change in receivables | ---- | 262.93%12.22M | ---- | ---- | ---- | ---- | 60.37%-7.5M | ---- | ---- | ---- |
| -Change in inventory | ---- | -104.03%-548K | ---- | ---- | ---- | ---- | 372.89%13.59M | ---- | ---- | ---- |
| -Change in payables | ---- | 800.49%5.71M | ---- | ---- | ---- | ---- | -109.95%-815K | ---- | ---- | ---- |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -121.77%-275K | -124K | ||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 13.46%-656K | -148.56%-4.22M | -20,163.64%-2.21M | -73.05%-867K | 41.90%-391K | -41.42%-758K | 64.41%-1.7M | 101.32%11K | -186.83%-501K | 86.00%-673K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -42.61%10.46M | 200.51%36.81M | 58.66%6.69M | -78.80%1.65M | 266.73%10.25M | 822.15%18.23M | 233.05%12.25M | -79.05%4.21M | 140.59%7.76M | 153.45%2.8M |
| Investing cash flow | ||||||||||
| Capital expenditures | ---- | -4.65%-360K | ---- | ---- | ---- | ---- | -0.29%-344K | ---- | ---- | ---- |
| Net PPE purchase and sale | 62.82%-754K | 62.56%-3.76M | 7.08%-709K | 120.09%678K | 48.59%-1.7M | 21.79%-2.03M | 58.25%-10.03M | 95.00%-763K | -27.61%-3.37M | 9.49%-3.3M |
| Net business purchase and sale | ---- | --0 | -11,300.00%-114K | ---- | ---- | ---- | 98.98%-123K | 100.00%-1K | ---- | ---- |
| Net investment product transactions | ---- | --0 | ---1.35M | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Advance cash and loans provided to other parties | -12.97%-331K | -516.71%-2.33M | ---847K | ---525K | ---660K | ---293K | -6.80%-377K | ---- | ---- | --0 |
| Repayment of advance payments to other parties and cash income from loans | --55K | --53K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest received (cash flow from investment activities) | -580.00%-24K | -77.94%15K | -221.05%-23K | -18.18%18K | 25.00%15K | -66.67%5K | -45.60%68K | -84.80%19K | 122.00%22K | -88.00%12K |
| Net changes in other investments | ---- | 8,164.71%2.74M | --0 | 2,209.52%443K | 1,945.45%203K | 510.18%2.1M | 98.53%-34K | 134.67%509K | -105.44%-21K | 98.29%-11K |
| Investing cash flow | -379.09%-1.05M | 66.02%-3.68M | -253.59%-3.4M | 159.38%2.07M | 35.17%-2.14M | 92.88%-220K | 73.18%-10.84M | 96.94%-961K | -102.26%-3.49M | 21.23%-3.3M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 80.02%-3.09M | -215.95%-25.48M | 64.61%-1.56M | 25.50%-4.66M | -6,142.86%-3.81M | -712.52%-15.45M | -2.81%-8.06M | -261.18%-4.4M | -386.54%-6.25M | 100.89%63K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Increase or decrease of lease financing | -68.20%-1.65M | 31.88%-2.18M | 70.06%-156K | 25.35%-804K | 62.88%-242K | -2.95%-978K | -9.36%-3.2M | -121.70%-521K | -340.40%-1.08M | 45.30%-652K |
| Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | 98.58%-11K | 26.00%-3.45M | 2.07%-1.37M | 61.37%-501K | 27.67%-805K | 9.25%-775K | 5.03%-4.66M | 38.20%-1.4M | -35.25%-1.3M | -69.41%-1.11M |
| Net other fund-raising expenses | 252.94%52K | -676.38%-1.15M | -842.06%-1.19M | -97.37%10K | -76.38%64K | 89.57%-34K | -74.78%199K | 65.85%-126K | 25.41%380K | -62.57%271K |
| Financing cash flow | 72.79%-4.69M | -105.09%-32.25M | 33.75%-4.27M | 27.81%-5.95M | -234.73%-4.79M | -4,487.02%-17.24M | -166.25%-15.73M | -2,725.44%-6.44M | -122.15%-8.25M | 82.53%-1.43M |
| Net cash flow | ||||||||||
| Beginning cash position | 48.72%2.67M | -88.86%1.79M | -26.79%3.65M | -34.32%5.88M | -76.50%2.56M | -88.86%1.79M | -61.63%16.11M | -81.99%4.98M | -20.77%8.96M | -62.33%10.89M |
| Current changes in cash | 515.54%4.72M | 106.11%874K | 69.27%-980K | 43.77%-2.23M | 271.77%3.32M | 114.67%766K | 44.68%-14.32M | 72.42%-3.19M | -124.27%-3.97M | 89.02%-1.93M |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | ---- |
| End cash Position | 188.51%7.38M | 48.72%2.67M | 48.72%2.67M | -26.79%3.65M | -34.32%5.88M | -76.50%2.56M | -88.86%1.79M | -88.86%1.79M | -81.99%4.98M | -20.77%8.96M |
| Free cash flow | -40.08%9.71M | 8,534.28%30.48M | 243.94%5.56M | -96.17%168K | 1,695.90%8.55M | 416.57%16.2M | 101.04%353K | -62.35%1.62M | 120.16%4.39M | 94.01%-536K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.